721 results on '"Guan, Xin-Yuan"'
Search Results
2. Fibroblasts in metastatic lymph nodes confer cisplatin resistance to ESCC tumor cells via PI16
3. Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression
4. Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction
5. Author Correction: Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma
6. PPM1G promotes cell proliferation via modulating mutant GOF p53 protein expression in hepatocellular carcinoma
7. Exploring treatment options in cancer: Tumor treatment strategies
8. HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer
9. LOXL1 promotes tumor cell malignancy and restricts CD8 + T cell infiltration in colorectal cancer
10. Optimal time for early therapeutic response prediction in nasopharyngeal carcinoma with functional magnetic resonance imaging
11. GLIPR1 promotes proliferation, metastasis and 5-fluorouracil resistance in hepatocellular carcinoma by activating the PI3K/PDK1/ROCK1 pathway
12. Roles of heat shock proteins in tumor immune microenvironment
13. Ferroptosis: Promising approach for cancer and cancer immunotherapy
14. The Origin, Differentiation, and Functions of Cancer-Associated Fibroblasts in Gastrointestinal Cancer
15. A T cell resilience model associated with response to immunotherapy in multiple tumor types
16. Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer
17. PITX2C increases the stemness features of hepatocellular carcinoma cells by up-regulating key developmental factors in liver progenitor
18. Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma
19. HN1L/AP-2γ/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma
20. Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma
21. Potential synthetic lethality for breast cancer: A selective sirtuin 2 inhibitor combined with a multiple kinase inhibitor sorafenib
22. Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor
23. Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
24. The RARS–MAD1L1 Fusion Gene Induces Cancer Stem Cell–like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma
25. A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets
26. PGC7 promotes tumor oncogenic dedifferentiation through remodeling DNA methylation pattern for key developmental transcription factors
27. DAPK3 inhibits gastric cancer progression via activation of ULK1-dependent autophagy
28. Correction: C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism
29. C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism
30. A neural‐related gene risk score for head and neck squamous cell carcinoma.
31. Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma
32. PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma
33. Correction to: CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17
34. Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma
35. RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2
36. Genome-wide identification of key regulatory lncRNAs in esophageal cancer metastasis
37. Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits
38. Publisher Correction: A T cell resilience model associated with response to immunotherapy in multiple tumor types
39. Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis
40. CHD1L augments autophagy-mediated migration of hepatocellular carcinoma through targeting ZKSCAN3
41. HOXC10 upregulation confers resistance to chemoradiotherapy in ESCC tumor cells and predicts poor prognosis
42. Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma
43. Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model
44. Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma
45. HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma
46. Membrane Metalloendopeptidase (MME) Suppresses Metastasis of Esophageal Squamous Cell Carcinoma (ESCC) by Inhibiting FAK-RhoA Signaling Axis
47. TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling
48. ApoA-1 accelerates regeneration of small-for-size fatty liver graft after transplantation
49. Correction: Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically down-regulating MTSS1 through DNMT3B
50. Loss of ESRP2 Activates TAK1‐MAPK Signaling through the Fetal RNA‐Splicing Program to Promote Hepatocellular Carcinoma Progression.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.